RVP RETRACTABLE TECHNOLOGIES INC
No recent data for RVP. Our end-of-day feed has carried no price for this security since 2026-09-02, and we found no SEC delisting or deregistration filing that would explain it — so this reflects the coverage of our data source. The security may still be trading, and quotes may be available elsewhere. Company filings and reported financials on this page are unaffected.
Updated
Healthcare · Surgical & Medical Instruments & Apparatus
RETRACTABLE TECHNOLOGIES INC (RVP) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $22 million. Price data for RVP is unavailable — our feed has carried no quote since 2026-09-02. Net profit margin is -9.9%, below the peer median of -9.3%. Revenue grew 15.8% year over year.
Chart hidden: no price data for RVP since 2026-09-02. Company filings and financials below are current.
Financials
Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $-0.05 | 2026-08-14 |
| Q1 2026 | $-0.14 | 2026-05-15 |
| FY 2025 | $-0.43 | 2026-03-27 |
| Q3 2025 | $-0.35 | 2025-11-14 |
| Q2 2026 | $-0.36 | 2026-08-14 |
| Q1 2026 | $-0.35 | 2026-05-15 |
Surgical & Medical Instruments & Apparatus peers
RVP vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated
| SYK | Stryker Corporation | $118.2B | 31.69 | 4.57 | 14.4% | -1.31% |
| MMM | 3M | $86.8B | 28.97 | 3.45 | 11.9% | -0.28% |
| BSX | Boston Scientific | $68.0B | 18.54 | 3.24 | 17.5% | -3.17% |
| BDX | Becton Dickinson | $51.1B | 54.30 | 2.45 | 4.5% | +0.00% |
| DXCM | DexCom | $33.9B | 33.86 | 6.81 | 20.1% | +0.02% |
| RMD | ResMed | $33.1B | 21.70 | 5.85 | 26.9% | -0.78% |
| MDLN | Medline Inc. | $30.7B | — | 1.08 | — | +0.88% |
| WST | West Pharmaceutical Services | $24.1B | 42.67 | 7.25 | 17.0% | +0.00% |
| SOLV | Solventum | $15.7B | 10.97 | 1.89 | 17.3% | +0.56% |
| BAX | Baxter International | $13.2B | -12.44 | 1.15 | -9.3% | -0.51% |
| PEN | Penumbra Inc | $12.7B | 78.81 | 9.02 | 11.4% | -0.46% |
| GKOS | Glaukos Corp | $10.6B | -56.59 | 17.36 | -30.7% | +0.52% |
| GMED | Globus Medical Inc | $10.5B | 19.59 | 3.34 | 17.0% | -3.14% |
| PODD | Insulet Corporation | $10.4B | 27.82 | 3.42 | 12.3% | +1.63% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.